InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (16 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
16
T+90 hit rate
50%
T+90 mean return
-0.1%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Ackermann Michael, Director. Insider active across 1 company, notably Tarsus Pharmaceuticals, Inc.. Cumulatively, 20 filings have been logged. Breakdown: 1 buy · 16 sells. Total volume traded: €2.1m. Activity tracked since 15 June 2021. The latest transaction was filed on 5 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations20 total
4,257 sharesCommon StockSEC:0001209191-22-037924:0
100,000 shares@ US$13.500.048% mcap59.9% of flowCommon StockSEC:0001209191-22-027856:0
Ideal exit: 30 Jan 2023 (T+270)
2,442 shares@ US$23.852.4% of flowCommon StockSEC:0001819790-21-000059
2,442 shares@ US$23.850.0019% mcap2.4% of flowCommon StockSEC:0001819790-21-000059:0
4,964 shares@ US$27.760.0044% mcap5.6% of flowCommon StockSEC:0001819790-21-000043:0
4,964 shares@ US$27.765.6% of flowCommon StockSEC:0001819790-21-000043
1,116 shares@ US$25.560.0009% mcap1.2% of flowCommon StockSEC:0001819790-21-000039:0
1,116 shares@ US$25.561.2% of flowCommon StockSEC:0001819790-21-000039
200 shares@ US$25.030.0002% mcap0.2% of flowCommon StockSEC:0001819790-21-000035:0
200 shares@ US$25.030.2% of flowCommon StockSEC:0001819790-21-000035
5,833 shares@ US$25.2420.0046% mcap5.8% of flowCommon StockSEC:0001209191-21-054888:0
5,833 shares@ US$25.2425.8% of flowCommon StockSEC:0001209191-21-054888
621 shares@ US$25.1520.0005% mcap0.6% of flowCommon StockSEC:0001209191-21-051193:0
621 shares@ US$25.1520.6% of flowCommon StockSEC:0001209191-21-051193
3,129 shares@ US$25.000.0025% mcap3.1% of flowCommon StockSEC:0001209191-21-050631:0
3,129 shares@ US$25.003.1% of flowCommon StockSEC:0001209191-21-050631
1,183 shares@ US$25.000.0009% mcap1.2% of flowCommon StockSEC:0001209191-21-050177:0
1,183 shares@ US$25.001.2% of flowCommon StockSEC:0001209191-21-050177
4,257 shares0Common StockSEC:0001209191-21-041701
4,257 shares0Common StockSEC:0001209191-21-041701:0
20 of 20 declarations
About Ackermann Michael
Michael Ackermann is an executive at Tarsus Pharmaceuticals, Inc.
